67: Molecular Profiling and Unnecessary Thyroid Surgeries with Jennifer Kuo from Columbia University

One-third of all thyroid nodule fine needle aspirations come back indeterminate. When surgery is performed on these cases, pathology of the thyroid reveals that many times the nodule is benign.  Through molecular profiling, patients with indeterminate thyroid nodules, can now avoid unnecessary surgery and get more accurate pathology results from the fine needle aspiration. Are you a patient and your doctor has said your thyroid nodule is indeterminate and is recommending surgery as an option?  The key is, to confirm that molecular profiling was performed.    Jennifer Kuo, MD is Director of the Thyroid Biopsy Program, Director of the Endocrine Surgery Research Program, and Instructor in Surgery, at the Columbia University Medical Center. 

Continue Reading

66: New Research Reveals Thyroid Surgery Errors 5x More Frequent Than Reported with Dr. Maria Papaleontiou from Michigan Medicine

Scheduled to publish next month, the statistics show thyroid surgery much less safe than thought. The findings that 12% of patients overall had thyroid surgery specific complications is concerning, but more concerning is surgeons quote a 1 to 3 percent rate of error. In the case of surgery for metastatic thyroid cancer, the error rate skyrockets to 23%. Dr. Maria Papaleontiou is an Assistant Professor of Internal Medicine with an appointment in the Division of Metabolism, Endocrinology and Diabetes.

Continue Reading

65: Thyroid Surgery? Be Careful, Not All Surgeons Are Equal and Here is Why with Dr. Ralph P. Tufano from Johns Hopkins School of Medicine

If you select carefully, the unwanted errors of thyroid surgery can be avoided. Dr. Ralph P. Tufano is the Director of the Division of Head and Neck Endocrine Surgery at The Johns Hopkins School of Medicine, and conducts thyroid and parathyroid surgery with a focus on optimizing outcomes. In this interview, items discussed include: * the emotional burden of being diagnosed with cancer and the haste that sometimes follows * the unnecessary damage of thyroid surgery, including the cutting of the laryngeal nerve resulting in vocal cord paralysis, low calcium levels and a need to supplement calcium and Vitamin D for life, and leaving residual disease behind * knowing your risk factor and finding the right medical team to address it

Continue Reading

64: 1 in 3 People Die With Thyroid Cancer — Not From with Dr. Seth Landefeld from UAB

1 in 3 People Die With Thyroid Cancer The USPSTF upholds its 1996 recommendation against screening for thyroid cancer among asymptomatic adults. The USPSTF commissioned the systematic review due to the rising incidence of thyroid cancers against a background of stable mortality, which is suggestive of over-treatment. And in view of the results, the task force concluded with “moderate certainty” that the harms outweigh the benefits of screening.

Continue Reading

60: What Happens When Thyroid Cancer Travels to the Lungs? with Dr. Fabian Pitoia from the Hospital of University of Buenos Aires

What Happens When Thyroid Cancer Travels to the Lungs? In this interview, Dr. Fabian Pitoia discusses the treatment for distant metastatic thyroid cancer. Topics discussed include: 10% of thyroid cancer patients will have distant metastatic disease The disease will travel to lungs, bones, or both Treatment with RAI is most effective for those under 40 years old Evaluation of metastatic thyroid cancer in the lungs is a CT scan In 2006, there was a change in the treatment of the disease

Continue Reading

59: ¿Qué Sucede Cuando el Cáncer de Tiroides va a los Pulmones? con el Doctor Fabian Pitoia del Hospital de Clínicas de la Universidad de Buenos Aires

Bienvenido al episodio 33 de Doctor Thyroid con Philip James.    El invitado de hoy es Dr. Fabian Pitoia.  El Dr. Pitoia es un experto endocrino mundial, que aparece en muchas publicaciones y conferencias mundiales, donde habla de cáncer de tiroides. El Dr Pitoia es médico endocrinólogo, está encargado de la Sección Tiroides de la División Endocrinología del Hospital de Clínicas de la Universidad de Buenos Aires. En este episodio, el Dr. Pitoia responde las siguientes preguntas: * ¿Qué es la enfermedad metastásica en relación con el cáncer de tiroides?   * Hay una tendencia de este enfermedad? * ¿cómo se descubre la enfermedad metastásica? * cuando se trata de cáncer de tiroides es un procedimiento típico para los médicos para detectar la enfermedad metastásica? * si un paciente no responde a RAI (radioactiva), ¿qué es una opción de tratamiento? ¿Podemos hacer vigilancia activa

Continue Reading
Close Menu

Subscribe to Doctor Thyroid with Philip James Newsletter

No spam. Your information is safe.
It will not be shared with any third party.
You can unsubscribe at any time.